A

Ailomics Therapeutics

5 employees

Ailomics Therapeutics focuses on developing innovative drugs to treat immune diseases and tumors.

Basic info

Industry

biotechnology research

Sectors

computational biology
omics data analysis
Biotechnology
deep learning
Therapeutics
AI
Pharmaceutical
immunology

Date founded

2022

Funding rounds raised

A

Ailomics Therapeutics raised undisclosed on May 31, 2023

Investors: Qiming Venture Partners

A

Ailomics Therapeutics raised undisclosed on August 9, 2022

Investors: Qiming Venture Partners

FAQ